title: Vigabatrin aggravates absences and absence status.
authors.forename: L
authors.initials: L
authors.lastname: Cocito
authors.forename: A
authors.initials: A
authors.lastname: Primavera
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use*; D001237:Asphyxia / Q000150:complications; D001925:Brain Damage, Chronic / Q000150:complications; D002220:Carbamazepine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004569:Electroencephalography; D004832:Epilepsy, Absence / Q000139:chemically induced* / Q000503:physiopathology; D004830:Epilepsy, Tonic-Clonic / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D008297:Male; D010634:Phenobarbital / Q000627:therapeutic use; D020888:Vigabatrin; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D000927:Anticonvulsants; D002220:Carbamazepine; D005680:gamma-Aminobutyric Acid; D020888:Vigabatrin; D010634:Phenobarbital